Cancer biopsies were obtained from patients with EOC admitted to the Second Hospital of Hebei Medical University from 2010 to 2013. All patients were confirmed by pathology and had complete clinic data and were followed up to 5 years post-surgery. Exclusion criteria: patients receiving endocrine therapy within the last 1 year, including oral contraceptives; Patients with primary malignant tumor combined with other systems; Patients with severe systemic infection, hyperthyroidism, hypothyroidism and other endocrine diseases. All samples were embedded in paraffin and incorporated into tissue microarrays by Shanghai Outdo Biotech Co., Ltd. There were 87 tissue cores with a diameter of 1.5 mm in a microarray block. The microarray included tissues from patients with papillary serous carcinoma (PSC, N=48), endometrioid ovarian carcinoma (EMC, N=6), mucinous ovarian carcinoma (MUC, N=12), clear cell ovarian carcinoma (CCC, N=4) and adjacent normal tissues to tumor (para-cancerous tissues, Para-ca, N=17). All samples involved in the study were obtained from perimenopausal or postmenopausal women. The patients' characteristics are shown in Table Table11.

Patient characteristics (N = 87)

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.